A Cleveland Clinic podcast for medical professionals exploring the latest innovative research and clinical advances in the field of oncology.
Cleveland Clinic's Center for Young-Onset Colorectal Cancer
Suneel Kamath, MD, hematologist and medical oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast for the second time to discuss our new Center for Young-Onset Colorectal Cancer. Listen as Dr. Kamath discusses how the center was established, and how it will allow us to take a comprehensive and multidisciplinary approach to research, diagnosis, and treatment of young-onset colorectal cancer.
Funding Disparities Affecting Cancers with High Mortality Rates
Hematologist and medical oncologist at Cleveland Clinic Cancer Center, Suneel Kamath, MD, joins the Cancer Advances podcast to discuss his research on funding disparities. Many cancers with higher mortality rates and high incidence are underfunded, including colorectal, lung, hepatobiliary and uterine cancers. Listen as Dr. Kamath discusses his research from the American Society of Clinical Oncology (ASCO) 2021 annual meeting, highlighting how critical funding is for advancing cancer research.
New Developments in Cell Therapy
Paolo Caimi, MD, Associate BMT Director for Cell Therapy at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss new developments and clinical trials in cell therapy. Listen as Dr. Caimi discusses how the field is changing, along with the primary advantages and disadvantages of using cellular therapy compared to chemotherapy.
Cardio-Oncology for Pediatric and Adult Cancer Patients
Pediatric heart failure and transplant cardiologist at Cleveland Clinic Children's, Shahnawaz Amdani, MD, joins the Cancer Advances podcast to discuss cardio-oncology for both pediatric and adult cancer patients who are undergoing chemotherapy or have completed their chemotherapy and are now long-term survivors. Listen as Dr. Amdani highlights when and how cardiac toxicity develops, preventative therapies and how the field has evolved.
Triple-Negative Breast Cancer Prevention Vaccine
Cleveland Clinic recently opened a clinical trial to determine the maximum tolerated dose of a vaccine in patients with non-metastatic triple-negative breast cancer (TNBC). The breast cancer vaccine was invented and developed by Cleveland Clinic immunologist Vincent Tuohy, PhD, and his research team. Cleveland Clinic medical oncologist and principal investigator, G. Thomas Budd, MD, joins the Cancer Advances podcast to discuss the trial origins and what we are looking to accomplish.
Our Approach to Community Outreach
Miriam Hernandez, Program Manager in Community Outreach at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about our approach to community outreach and how we’re helping to educate and provide cancer screenings for the underserved population. Listen as Miriam highlights how the community outreach program initially started, what initiatives they are actively doing within the community, and how they are making a difference.